
Economic Burden of Intravenous Decitabine Administration in Patients Affected by Acute Myeloid Leukemia Ineligible for ...
Introduction Acute myeloid leukemia (AML) is a hematopoietic malignancy of bone marrow stem cells with abnormal differentiation and clonal accumulation of myeloid stem cells.1–3 In Italy, there is an estimated annual incidence of 3.5 cases per 100,000 …